Terms: = Thyroid cancer AND CARS, P49589, 833, ENSG00000110619 AND Prognosis
7 results:
1. A novel nomogram and recursive partitioning analysis for predicting cancer-specific survival of patients with subcutaneous leiomyosarcoma.
Ji Q; Hu H; Li S; Tang J
Sci Rep; 2024 Feb; 14(1):2861. PubMed ID: 38311615
[TBL] [Abstract] [Full Text] [Related]
2. The diagnostic value of ultrasound on different-sized thyroid nodules based on ACR TI-RADS.
Li W; Chen J; Ye F; Xu D; Fan X; Yang C
Endocrine; 2023 Dec; 82(3):569-579. PubMed ID: 37656349
[TBL] [Abstract] [Full Text] [Related]
3. Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy.
Ju Y; Wang L; Cheng F; Huang F; Chen X; Song Q; Xiao J; Zhu X; Jia H
BMC Endocr Disord; 2023 Jan; 23(1):19. PubMed ID: 36670396
[TBL] [Abstract] [Full Text] [Related]
4. The Effect of HER2 Status on Metaplastic Breast cancer A Propensity Score-Matched Analysis.
Hu J; Zhang Y; Dong F; Shen J; Chen H; Li L; Huang T
Front Endocrinol (Lausanne); 2022; 13():874815. PubMed ID: 35928894
[TBL] [Abstract] [Full Text] [Related]
5. Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patients.
Zou J; Gu Y; Zhu Q; Li X; Qin L
Cancer Biomark; 2022; 34(3):393-401. PubMed ID: 35068448
[TBL] [Abstract] [Full Text] [Related]
6. Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma.
Kim YN; Kim M; Ahn HS; Kim K; Park SY; Kim HI; Jeon MJ; Kim WG; Kim SW; Kim WB; Chung JH; Shong YK; Kim TY; Kim TH
Oral Oncol; 2019 Feb; 89():8-13. PubMed ID: 30732964
[TBL] [Abstract] [Full Text] [Related]
7. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract] [Full Text] [Related]